Home > Qtrly Results > COHANCE LIFESCIENCES

COHANCE LIFESCIENCES
Quarterly Results Analysis [Mar2026]

COHANCE LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for COHANCE LIFESCIENCES
Please provide your vote to see the results

COHANCE LIFESCIENCES Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹619 Cr ₹545 Cr ₹556 Cr ₹549 Cr ₹840 Cr ₹676 Cr ₹604 Cr ₹488 Cr
Expenses ₹520 Cr ₹449 Cr ₹435 Cr ₹437 Cr ₹611 Cr ₹439 Cr ₹398 Cr ₹363 Cr
Operating Income ₹99 Cr ₹95 Cr ₹121 Cr ₹112 Cr ₹229 Cr ₹237 Cr ₹205 Cr ₹125 Cr
Other Income ₹-2 Cr ₹6 Cr ₹16 Cr ₹14 Cr ₹12 Cr ₹22 Cr ₹16 Cr ₹19 Cr
Interest ₹9 Cr ₹9 Cr ₹9 Cr ₹10 Cr ₹10 Cr ₹11 Cr ₹10 Cr ₹10 Cr
Depreciation ₹51 Cr ₹47 Cr ₹44 Cr ₹45 Cr ₹54 Cr ₹44 Cr ₹38 Cr ₹31 Cr
Profit Before Tax ₹20 Cr ₹41 Cr ₹84 Cr ₹63 Cr ₹161 Cr ₹205 Cr ₹174 Cr ₹103 Cr
Profit After Tax ₹8 Cr ₹29 Cr ₹66 Cr ₹46 Cr ₹117 Cr ₹153 Cr ₹138 Cr ₹75 Cr
EPS ₹0.51 ₹0.96 ₹1.94 ₹1.28 ₹4.73 ₹6.01 ₹5.44 ₹2.96
Industry Peers & Returns1W1M1Y
COHANCE LIFESCIENCES -6% -3.4% -59.2%
SUN PHARMACEUTICAL INDUSTRIES 3.5% -1.5% 9%
DIVIS LABORATORIES 1.1% -1.1% 0.8%
TORRENT PHARMACEUTICALS -0.2% -0.3% 35%
CIPLA 3.1% 1% -11.3%
DR REDDYS LABORATORIES 1.1% -2.1% -5.6%
MANKIND PHARMA 7.7% 0.9% 2.1%
LUPIN 2.7% 2.4% 17%
ZYDUS LIFESCIENCES 0.6% 4.7% 10%

COHANCE LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

13.69 %

Y-o-Y

-26.33 %

Quarters Revenues % Change
Mar2026 ₹619 Cr
13.69
Dec2025 ₹545 Cr
-1.98
Sep2025 ₹556 Cr
1.14
Jun2025 ₹549 Cr
-34.64
Mar2025 ₹840 Cr
24.28
Dec2024 ₹676 Cr
12.00
Sep2024 ₹604 Cr
23.70
Jun2024 ₹488 Cr -

COHANCE LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

3.49 %

Y-o-Y

-56.95 %

Quarters Operating Profit % Change
Mar2026 ₹99 Cr
3.49
Dec2025 ₹95 Cr
-21.17
Sep2025 ₹121 Cr
7.98
Jun2025 ₹112 Cr
-51.13
Mar2025 ₹229 Cr
-3.43
Dec2024 ₹237 Cr
15.58
Sep2024 ₹205 Cr
64.16
Jun2024 ₹125 Cr -
Operating Margins
Q-o-Q

-8.97 %

Y-o-Y

-41.55 %

Quarters Operating Margin% % Change
Mar2026 15.94%
-8.97
Dec2025 17.51%
-19.57
Sep2025 21.77%
6.77
Jun2025 20.39%
-25.23
Mar2025 27.27%
-22.31
Dec2024 35.1%
3.20
Sep2024 34.01%
32.70
Jun2024 25.63% -

COHANCE LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-71.36 %

Y-o-Y

-92.91 %

Quarters Profit After Tax % Change
Mar2026 ₹8 Cr
-71.36
Dec2025 ₹29 Cr
-56.29
Sep2025 ₹66 Cr
43.08
Jun2025 ₹46 Cr
-60.39
Mar2025 ₹117 Cr
-23.67
Dec2024 ₹153 Cr
11.02
Sep2024 ₹138 Cr
83.42
Jun2024 ₹75 Cr -
PAT Margins
Q-o-Q

-74.86 %

Y-o-Y

-90.39 %

Quarters PAT Margin(%) % Change
Mar2026 1.34 %
-74.86
Dec2025 5.33 %
-55.40
Sep2025 11.95 %
41.42
Jun2025 8.45 %
-39.38
Mar2025 13.94 %
-38.59
Dec2024 22.7 %
-0.87
Sep2024 22.9 %
48.32
Jun2024 15.44 % -

COHANCE LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-46.88 %

Y-o-Y

-89.22 %

Quarters EPS % Change
Mar2026 ₹0.51
-46.88
Dec2025 ₹0.96
-50.52
Sep2025 ₹1.94
51.56
Jun2025 ₹1.28
-72.94
Mar2025 ₹4.73
-21.30
Dec2024 ₹6.01
10.48
Sep2024 ₹5.44
83.78
Jun2024 ₹2.96 -

You may also like the below Video Courses